Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer | NEJM
Adjuvant therapy with durvalumab, with or without tremelimumab, may have efficacy in patients with limited-stage small-cell lung cancer who do not have disease progression after standard concurrent…